Tipifarnib in Subjects With Myelodysplastic Syndromes
Clinical trial NCT02779777 · TERMINATED
Trial details
- NCT number
- NCT02779777
- Sponsor
- Kura Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-08-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.